Introduction Accurate prognostication is difficult in malignant pleural mesothelioma (MPM).
We developed a set of robust computational models to quantify the prognostic value of …

Cancer-associated cachexia (CAC) is a major contributor to morbidity and mortality in
individuals with non-small cell lung cancer. Key features of CAC include alterations in body …

Background and objective Non‐expansile lung (NEL) frequently complicates management
of malignant pleural effusion (MPE) and is an important factor in clinical practice and trials. …

The use of prescription drugs in older people is high and many commonly prescribed drugs
have anticholinergic effects. We examined the relationship between ACB on mortality and in-…

Background In malignant pleural mesothelioma (MPM), complex tumour morphology results
in inconsistent radiological response assessment. Promising volumetric methods require …

… Martin MBChB a b , Selina Tsim PhD a b , Andrew C. Kidd MBChB a , John E. Foster PhD
c , Philip McLoone MSc d , Anthony Chalmers PhD b e , Kevin G. Blyth MD a f …

Background: the mortality is high in acutely ill oldest old patients. Understanding the
prognostic factors which influence mortality will help clinicians make appropriate management …

Malignant Pleural Mesothelioma (MPM) is a cancer associated with prior exposure to
asbestos fibres. Unlike most tumours, which are roughly spherical, MPM grows like a rind …

Introduction Non-expansile lung (NEL) is a common cause of talc pleurodesis (TP) failure in
malignant pleural effusion (MPE), but is often occult prior to drainage. Reliable detection of …

Early identification of cancer cachexia may facilitate stratification of patients most-at-risk and
initiation of emerging anticachexia treatments. If these are proven to be effective, this …